Stay updated with breaking news from Matt abernethy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, May 2, 2023 /PRNewswire/ Neurocrine Biosciences, Inc. will present at the Bank of America Securities 2023 Healthcare Conference at 10:00 a.m. Pacific Time on Tuesday, May 9, 2023.. | May 2, 2023 ....
Los Angeles Capital Management LLC cut its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 3.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 763,692 shares of the company’s stock after selling 28,274 shares during the period. […] ....
Mach 1 Financial Group LLC acquired a new stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 5,244 shares of the company’s stock, valued at approximately $626,000. Several other institutional investors also […] ....
Congress Asset Management Co. MA trimmed its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 16.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 917,825 shares of the company’s stock after selling 176,352 shares during the period. […] ....
/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in March. Kevin Gorman, Chief Executive. ....